BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16188147)

  • 1. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
    Feng C; Li HZ; Yan WG; Luo YF; Cao JL
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
    APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant adrenal tumors.
    Rescorla FJ
    Semin Pediatr Surg; 2006 Feb; 15(1):48-56. PubMed ID: 16458846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenal incidentalomas: report of 126 cases].
    Li HZ; Yan WG; Wang W; Xia M; Wang HJ; Liu GH
    Zhonghua Wai Ke Za Zhi; 2004 Jan; 42(2):97-9. PubMed ID: 15009991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.
    Khorram-Manesh A; Ahlman H; Jansson S; Nilsson O
    Endocr Pathol; 2002; 13(2):99-110. PubMed ID: 12165657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of argyrophilic proteins from the nucleolar organizer regions as an index of maturity degree of benign and malignant adrenal tumors].
    Raĭkhlin NT; Bukaeva IA; Baronin AA; Probatova NA; Smirnova EA; Bronshteĭn MI
    Arkh Patol; 2002; 64(3):26-30. PubMed ID: 15338720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dysfunction of the aldosterone synthesis pathway as a marker of malignity in symptomatic and asymptomatic adrenal masses].
    Aupetit-Faisant B; Blanchouin N; Legrand JC
    Bull Acad Natl Med; 1995 Oct; 179(7):1355-65; discussion 1365-7. PubMed ID: 8556410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery of adrenal tumors].
    Bondarenko VO; Ermolov AS; Kovalenko TI; Kondratiev AV
    Khirurgiia (Mosk); 2004; (5):61-4. PubMed ID: 15159762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
    Giovanella L; Squin N; Ghelfo A; Ceriani L
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
    Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases.
    Kamio T; Shigematsu K; Kawai K; Tsuchiyama H
    Am J Pathol; 1991 Jan; 138(1):83-91. PubMed ID: 1702931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Mucci NR; Akdas G; Manely S; Rubin MA
    Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of various imaging modalities for diagnostic work-up of tumors of the adrenal gland].
    Zech CJ; Weiss M; Schoenberg SO; Herrmann KA; Helmberger T; Reiser MF
    Radiologe; 2003 Apr; 43(4):284-92. PubMed ID: 12721644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
    Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
    Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnosis and management of adrenal "incidentaloma"].
    Chao CS; Zhou ZG; Liao EY
    Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):395-7. PubMed ID: 7867431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
    Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
    Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.